{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:22:10Z","timestamp":1780705330348,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bioorg.2022.105899","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:08:39Z","timestamp":1653473319000},"page":"105899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["N-Acetyl-l-tryptophan inhibits CCl4-induced hepatic fibrogenesis via regulating TGF-\u03b21\/SMAD and Hippo\/YAP1 signal"],"prefix":"10.1016","volume":"126","author":[{"given":"Tingting","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bioorg.2022.105899_b0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12 Suppl","key":"10.1016\/j.bioorg.2022.105899_b0010","first-page":"S210","article-title":"Guidance for supplemental enteral nutrition across patient populations","volume":"23","author":"Nguyen","year":"2017","journal-title":"Am. J. Manag. Care"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105899_b0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12325-018-0670-8","article-title":"Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design","volume":"35","author":"Zang","year":"2018","journal-title":"Adv. Ther"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105899_b0020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yexcr.2018.07.011","article-title":"Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15","volume":"370","author":"Dong","year":"2018","journal-title":"Exp. Cell. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105899_b0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105899_b0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105899_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of Liver Fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin. Liver. Dis"},{"key":"10.1016\/j.bioorg.2022.105899_b0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2019.03.064","article-title":"Nicotinamide riboside protects against liver fibrosis induced by CCl(4) via regulating the acetylation of Smads signaling pathway","volume":"225","author":"Jiang","year":"2019","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105899_b0045","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-\u03b2 signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"Febs. J."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105899_b0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.bioorg.2022.105899_b0055","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/gressner","article-title":"Roles of TGF-beta in hepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105899_b0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth. Factors"},{"issue":"8","key":"10.1016\/j.bioorg.2022.105899_b0065","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ncb2303","article-title":"The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal","volume":"13","author":"Zhao","year":"2011","journal-title":"Nat. Cell. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105899_b0070","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","article-title":"Elucidation of a universal size-control mechanism in Drosophila and mammals","volume":"130","author":"Dong","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bioorg.2022.105899_b0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.molmed.2015.01.003","article-title":"Disease implications of the Hippo\/YAP pathway","volume":"21","author":"Plouffe","year":"2015","journal-title":"Trends. Mol. Med."},{"issue":"14","key":"10.1016\/j.bioorg.2022.105899_b0080","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes. Dev."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105899_b0085","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.celrep.2013.10.030","article-title":"Bile acids activate YAP to promote liver carcinogenesis","volume":"5","author":"Anakk","year":"2013","journal-title":"Cell. Rep."},{"issue":"291","key":"10.1016\/j.bioorg.2022.105899_b0090","doi-asserted-by":"crossref","first-page":"ra77","DOI":"10.1126\/scisignal.2004060","article-title":"The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis","volume":"6","author":"Yi","year":"2013","journal-title":"Sci. Signal"},{"issue":"3","key":"10.1016\/j.bioorg.2022.105899_b0095","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105899_b0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.28542","article-title":"Hedgehog regulates yes-associated protein 1 in regenerating mouse liver","volume":"64","author":"Swiderska-Syn","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105899_b0105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.devcel.2010.11.012","article-title":"The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-\u03b2-SMAD pathway","volume":"19","author":"Varelas","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bioorg.2022.105899_b0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2015.05.002","article-title":"N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model","volume":"80","author":"Li","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105899_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034138","article-title":"Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease","volume":"7","author":"Thornton","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bioorg.2022.105899_b0120","doi-asserted-by":"crossref","first-page":"538s","DOI":"10.1080\/07315724.2004.10719398","article-title":"A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats","volume":"23","author":"Vink","year":"2004","journal-title":"J. Am. Coll. Nutr."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105899_b0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2013.02.031","article-title":"Autophagy in the liver","volume":"59","author":"Codogno","year":"2013","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105899_b0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/13880209.2019.1617750","article-title":"Protective role of N-acetyl-l-tryptophan against hepatic ischemia-reperfusion injury via the RIP2\/caspase-1\/IL-1\u03b2 signaling pathway","volume":"57","author":"Wang","year":"2019","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bioorg.2022.105899_b0135","article-title":"Inhibition of excessive mitophagy by N-acetyl-L-tryptophan confers hepatoprotection against Ischemia-Reperfusion injury in rats","volume":"8","author":"Li","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.bioorg.2022.105899_b0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.fct.2019.02.032","article-title":"Protective effects of ginsenoside Rk3 against chronic alcohol-induced liver injury in mice through inhibition of inflammation, oxidative stress, and apoptosis","volume":"126","author":"Qu","year":"2019","journal-title":"Food. Chem. Toxicol."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105899_b0145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41419-020-02811-4","article-title":"The critical role of PPAR\u03b1 in the binary switch between life and death induced by endoplasmic reticulum stress","volume":"11","author":"Xu","year":"2020","journal-title":"Cell. Death. Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105899_b0150","first-page":"185","article-title":"Postulated carbon tetrachloride mode of action: a review","volume":"25","author":"Manibusan","year":"2007","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.bioorg.2022.105899_b0155","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.2147\/DDDT.S179876","article-title":"Asiatic acid ameliorates CCl(4)-induced liver fibrosis in rats: involvement of Nrf2\/ARE, NF-\u03baB\/I\u03baB\u03b1, and JAK1\/STAT3 signaling pathways","volume":"12","author":"Fan","year":"2018","journal-title":"Drug. Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105899_b0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105899_b0165","article-title":"Total Antioxidant Capacity in HBV Carriers, a Promising Biomarker for Evaluating Hepatic Fibrosis: A Pilot Study","volume":"10","author":"Wang","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bioorg.2022.105899_b0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Annu. Rev. Pathol"},{"key":"10.1016\/j.bioorg.2022.105899_b0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: Direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105899_b0180","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12906-019-2560-2","article-title":"Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-\u03b2\/miR-195\/Smad signaling pathway","volume":"19","author":"Song","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105899_b0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","article-title":"Treatment of hepatitis C: a systematic review","volume":"312","author":"Kohli","year":"2014","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105899_b0190","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.1840120621","article-title":"Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin","volume":"12","author":"Lieber","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.bioorg.2022.105899_b0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biochi.2017.05.017","article-title":"Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo\/Yap and TGF-\u03b21\/Smad signaling","volume":"140","author":"Perumal","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.bioorg.2022.105899_b0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/HMER.S230613","article-title":"Evaluating the therapeutic potential of cenicriviroc in the treatment of nonalcoholic steatohepatitis with fibrosis: a brief report on emerging data","volume":"12","author":"Diaz Soto","year":"2020","journal-title":"Hepat. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105899_b0205","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/lt.25934","article-title":"Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis","volume":"27","author":"Weinberg","year":"2021","journal-title":"Liver. Transpl."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105899_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-020-00344-1","article-title":"Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism","volume":"12","author":"Yan","year":"2021","journal-title":"Biol. Sex. Differ."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105899_b0215","doi-asserted-by":"crossref","first-page":"14717","DOI":"10.1096\/fj.201901079RR","article-title":"Serelaxin inhibits the profibrotic TGF-\u03b21\/IL-1\u03b2 axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts","volume":"33","author":"C\u00e1ceres","year":"2019","journal-title":"Faseb. J."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105899_b0220","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/gut.2008.174904","article-title":"Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats","volume":"59","author":"Yue","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.bioorg.2022.105899_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104720","article-title":"Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy","volume":"155","author":"Cai","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2022.105899_b0230","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fimmu.2020.00323","article-title":"The Crosstalk Between Hippo-YAP Pathway and Innate Immunity","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2022.105899_b0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ceb.2019.07.006","article-title":"Role of the transcriptional coactivators YAP\/TAZ in liver cancer","volume":"61","author":"Zhang","year":"2019","journal-title":"Curr. Opin. Cell. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105899_b0240","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1038\/s41467-020-19229-3","article-title":"YAP and TAZ protect against white adipocyte cell death during obesity","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2022.105899_b0245","doi-asserted-by":"crossref","first-page":"3696914","DOI":"10.1155\/2018\/3696914","article-title":"How Hippo Signaling Pathway Modulates Cardiovascular Development and Diseases","volume":"2018","author":"Zhou","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105899_b0250","doi-asserted-by":"crossref","first-page":"L377","DOI":"10.1152\/ajplung.00024.2020","article-title":"Role of the COX2-PGE(2) axis in S. pneumoniae-induced exacerbation of experimental fibrosis","volume":"320","author":"Bormann","year":"2021","journal-title":"Am. J. Physiol. Lung. Cell. Mol. Physiol."},{"key":"10.1016\/j.bioorg.2022.105899_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153294","article-title":"Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-\u03b2\/Smad and YAP signaling","volume":"78","author":"Xiang","year":"2020","journal-title":"Phytomedicine"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822003042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822003042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:36:08Z","timestamp":1758616568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822003042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":51,"alternative-id":["S0045206822003042"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105899","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-Acetyl-l-tryptophan inhibits CCl4-induced hepatic fibrogenesis via regulating TGF-\u03b21\/SMAD and Hippo\/YAP1 signal","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105899"}}